|
1
|
Robert C, Karaszewska B, Schachter J,
Rutkowski P, Mackiewicz A, Stroiakovski D, Lichinitser M, Dummer R,
Grange F, Mortier L, et al: Improved overall survival in melanoma
with combined dabrafenib and trametinib. N Engl J Med. 372:30–39.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stadler S, Weina K, Gebhardt C and Utikal
J: New therapeutic options for advanced non-resectable malignant
melanoma. Adv Med Sci. 60:83–88. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Miles GD, Seiler M, Rodriguez L, Rajagopal
G and Bhanot G: Identifying microRNA/mRNA dysregulations in ovarian
cancer. BMC Res Notes. 5:1642012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ha M and Kim VN: Regulation of microRNA
biogenesis. Nat Rev Mol Cell Biol. 15:509–524. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Caramuta S, Egyházi S, Rodolfo M, Witten
D, Hansson J, Larsson C and Lui WO: MicroRNA expression profiles
associated with mutational status and survival in malignant
melanoma. J Invest Dermatol. 130:2062–2070. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lin S and Gregory RI: MicroRNA biogenesis
pathways in cancer. Nat Rev Cancer. 15:321–333. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Howe JR VI, Li ES, Streeter SE, Rahme GJ,
Chipumuro E, Russo GB, Litzky JF, Hills LB, Rodgers KR, Skelton PD
and Luikart BW: MiR-338-3p regulates neuronal maturation and
suppresses glioblastoma proliferation. PLoS One. 12:e01776612017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Han J, Li J, Tang K, Zhang H, Guo B, Hou N
and Huang C: miR-338-3p confers 5-fluorouracil resistance in p53
mutant colon cancer cells by targeting the mammalian target of
rapamycin. Exp Cell Res. 360:328–336. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kostina A, Bjork H, Ignatieva E, Irtyuga
O, Uspensky V, Semenova D, Maleki S, Tomilin A, Moiseeva O,
Franco-Cereceda A, et al: Notch, BMP and WNT/β-catenin network is
impaired in endothelial cells of the patients with thoracic aortic
aneurysm. Atheroscler Supp. 35:e6–e13. 2018. View Article : Google Scholar
|
|
10
|
Cao Y, Shi X, Liu Y, Xu R and Ai Q:
MicroRNA-338-3p inhibits proliferation and promotes apoptosis of
multiple myeloma cells through targeting Cyclin-dependent kinase 4.
Oncol Res. 27:117–124. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lee YJ, Cho JM, Moon JH, Ku CR, Kim J, Kim
SH and Lee EJ: Increased miR-338-3p expression correlates with
invasiveness of GH-producing pituitary adenomas. Endocrine.
58:184–189. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang P, Shao G, Lin X, Liu Y and Yang Z:
MiR-338-3p inhibits the growth and invasion of non-small cell lung
cancer cells by targeting IRS2. Am J Cancer Res. 7:53–63.
2017.PubMed/NCBI
|
|
13
|
Xiao G, Wang Q, Li B, Wu X, Liao H, Ren Y
and Ai N: MicroRNA-338-3p suppresses proliferation of human liver
cancer cells by targeting SphK2. Oncol Res. 26:1183–1189. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pinto R, Strippoli S, De Summa S, Albano
A, Azzariti A, Guida G, Popescu O, Lorusso V, Guida M and Tommasi
S: MicroRNA expression in BRAF-mutated and wild-type metastatic
melanoma and its correlation with response duration to BRAF
inhibitors. Expert Opin Ther Targets. 19:1027–1035. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang Q, Xu P, Lu Y and Dou H: Correlation
of MACC1/c-Myc expression in endometrial carcinoma with
clinical/pathological features or prognosis. Med Sci Monit.
24:4738–4744. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guo L, Ou S, Ma X, Zhang S and Lai Y:
MACC1 silencing inhibits cell proliferation and induces cell
apoptosis of lung adenocarcinoma cells through the β-catenin
pathway. Neoplasma. 65:552–560. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li S, Zhu J, Li J, Li S and Li B:
MicroRNA-141 inhibits proliferation of gastric cardia
adenocarcinoma by targeting MACC1. Arch Med Sci. 14:588–596. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Stein U, Walther W, Arlt F, Schwabe H,
Smith J, Fichtner I, Birchmeier W and Schlag PM: MACC1, a newly
identified key regulator of HGF-MET signaling, predicts colon
cancer metastasis. Nat Med. 15:59–67. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shimokawa H, Uramoto H, Onitsuka T,
Chundong G, Hanagiri T, Oyama T and Yasumoto K: Overexpression of
MACC1 mRNA in lung adenocarcinoma is associated with postoperative
recurrence. J Thorac Cardiovasc Surg. 141:895–898. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Feng J, Wang J, Chen M, Chen G, Wu Z, Ying
L, Zhuo Q, Zhang J and Wang W: miR-200a suppresses cell growth and
migration by targeting MACC1 and predicts prognosis in
hepatocellular carcinoma. Oncol Rep. 33:713–720. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Huang N, Wu Z, Lin L, Zhou M, Wang L, Ma
H, Xia J, Bin J, Liao Y and Liao W: MiR-338-3p inhibits
epithelial-mesenchymal transition in gastric cancer cells by
targeting ZEB2 and MACC1/Met/Akt signaling. Oncotarget.
6:15222–15234. 2015.PubMed/NCBI
|
|
22
|
YU SW, Liu HY and Luo LJ: Analysis of
relative gene expression using different real-time quantitative
PCR. Acta Agron Sin. 33:1214–1218. 2007.
|
|
23
|
Sandru A, Voinea S, Panaitescu E and
Blidaru A: Survival rates of patients with metastatic malignant
melanoma. J Med Life. 7:572–576. 2014.PubMed/NCBI
|
|
24
|
Acunzo M, Romano G, Wernicke D and Croce
CM: MicroRNA and cancer-a brief overview. Adv Biol Regul. 57:1–9.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Peng Y, Chen FF, Ge J, Zhu JY, Shi XE, Li
X, Yu TY, Chu GY and Yang GS: miR-429 inhibits differentiation and
promotes proliferation in porcine preadipocytes. Int J Mol Sci.
17(pii): E20472016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Miao X, Wang Z, Chen B, Chen Y, Wang X,
Jiang L, Jiang S, Hao K and Zhang W: miR-140-5p suppresses
retinoblastoma cell proliferation, migration, and invasion by
targeting CEMIP and CADM3. Cell Mol Biol (Noisy-le-grand).
64:42–47. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Huang XH, Chen JS, Wang Q, Chen XL, Wen L,
Chen LZ, Bi J, Zhang LJ, Su Q and Zeng WT: miR-338-3p suppresses
invasion of liver cancer cell by targeting smoothened. J Pathol.
225:463–472. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen X, Pan M, Han L, Lu H, Hao X and Dong
Q: miR-338-3p suppresses neuroblastoma proliferation, invasion and
migration through targeting PREX2a. FEBS Lett. 587:3729–3737. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Van Peer G, Mets E, Claeys S, De Punt I,
Lefever S, Ongenaert M, Rondou P, Speleman F, Mestdagh P and
Vandesompele J: A high-throughput 3′ UTR reporter screening
identifies microRNA interactomes of cancer genes. PLoS One.
13:e01940172018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shang C, Hong Y, Guo Y and Xue YX:
Mir-338-3p inhibits malignant biological behaviors of glioma cells
by targeting MACC1 gene. Med Sci Monit. 22:710–716. 2016.PubMed/NCBI
|
|
31
|
Li L and Li W: Epithelial-mesenchymal
transition in human cancer: Comprehensive reprogramming of
metabolism, epigenetics, and differentiation. Pharmacol Ther.
150:33–46. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Eger A, Aigner K, Sonderegger S, Dampier
B, Oehler S, Schreiber M, Berx G, Cano A, Beug H and Foisner R:
DeltaEF1 is a transcriptional repressor of E-cadherin and regulates
epithelial plasticity in breast cancer cells. Oncogene.
24:2375–2385. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Comijn J, Berx G, Vermassen P, Verschueren
K, van Grunsven L, Bruyneel E, Mareel M, Huylebroeck D and van Roy
F: The two-handed E box binding zinc finger protein SIP1
downregulates E-cadherin and induces invasion. Mol Cell.
7:1267–1278. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hazan RB, Phillips GR, Qiao RF, Norton L
and Aaronson SA: Exogenous expression of N-cadherin in breast
cancer cells induces cell migration, invasion, and metastasis. J
Cell Biol. 148:779–790. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li M, Zhang B, Sun B, Wang X, Ban X, Sun
T, Liu Z and Zhao X: A novel function for vimentin: The potential
biomarker for predicting melanoma hematogenous metastasis. J Exp
Clin Cancer Res. 29:1092010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Satelli A and Li S: Vimentin in cancer and
its potential as a molecular target for cancer therapy. Cell Mol
Life Sci. 68:3033–3046. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Essers J, Theil AF, Baldeyron C, van
Cappellen WA, Houtsmuller AB, Kanaar R and Vermeulen W: Nuclear
dynamics of PCNA in DNA replication and repair. Mol Cell Biol.
25:9350–9359. 2005. View Article : Google Scholar : PubMed/NCBI
|
